BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Peng DZ, Lu J, Li B, Hu HJ, Ye XW, Xiong XZ, Cheng NS. A simple scoring system to predict early recurrence of Bismuth-Corlette type IV perihilar cholangiocarcinoma. Gastroenterol Rep (Oxf) 2019;7:345-53. [PMID: 31687154 DOI: 10.1093/gastro/goz012] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Kang H, Kim JH, Joo I, Chang W. Important CT Findings for Prediction of Incomplete (R1 or R2) Resection and Poor Survival of Perihilar Cholangiocarcinoma after Curative-Intent Surgery. Korean J Abdom Radiol 2022;6:37-50. [DOI: 10.52668/kjar.2022.00136] [Reference Citation Analysis]
2 Jianxiong W, Yu W, Juyi W, Guangxia W. Intravenous combined with intrabiliary contrast-enhanced ultrasound in the evaluation of resectability of hilar cholangiocarcinomas. J Clin Ultrasound 2022. [PMID: 35808898 DOI: 10.1002/jcu.23268] [Reference Citation Analysis]
3 Chen T, Wang H, Yan H. miR-28-5p inhibits cholangiocarcinoma progression and predicts good prognosis of patients. Cell Cycle 2022;:1-12. [PMID: 35670491 DOI: 10.1080/15384101.2022.2085359] [Reference Citation Analysis]
4 Zhao J, Zhang W, Zhu YY, Zheng HY, Xu L, Zhang J, Liu SY, Li FY, Song B. Development and Validation of Noninvasive MRI-Based Signature for Preoperative Prediction of Early Recurrence in Perihilar Cholangiocarcinoma. J Magn Reson Imaging 2021. [PMID: 34296802 DOI: 10.1002/jmri.27846] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
5 Park HJ, Han DH, Choi GH, Choi JS. Surgical outcomes of perihilar cholangiocarcinoma based on the learning curve of a single surgeon at a tertiary academic hospital: A retrospective study. Ann Hepatobiliary Pancreat Surg 2021;25:54-61. [PMID: 33649255 DOI: 10.14701/ahbps.2021.25.1.54] [Reference Citation Analysis]
6 Bednarsch J, Neumann UP, Lurje G. Reply to: Does lymphovascular invasion really associate with decreased overall survival for patients with resected cholangiocarcinoma? European Journal of Surgical Oncology 2019;45:1513-4. [DOI: 10.1016/j.ejso.2019.05.030] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]